Demonstrating its expertise in precision materials engineering, Applied Materials, Inc. today announced two new systems that help customers solve critical challenges in manufacturing high-performance, power-efficient 3D devices.
Vorbeck Materials Corp., a world leader in the field of graphene, has entered into a strategic investment and technology development agreement with In-Q-Tel, Inc., the independent strategic investment firm that identifies innovative technology solutions to support the missions of the U.S. Intelligence Community.
Applied Materials, Inc. today announced the Applied Varian VIISta 900 3D system, the industry's state-of-the-art medium-current ion implantation tool developed for manufacturing FinFET and 3D NAND designs at sub-2x nanometer nodes.
Swedish pharmaceutical company Oasmia Pharmaceutical AB announced that a research agreement has been signed between Oasmia and a global pharmaceutical company. The agreement relates to the use of Oasmia's patented nanoparticle formulation technology XR-17.
The proceeds will be used for completing the development of Nanography, Landa's water-based digital printing process, including engineering and production ramp-up of Landa Nanographic Printing Presses and building of manufacturing plants for Landa NanoInk colorants.
Endomagnetics, the company developing a portfolio of products to improve the standard of cancer care, announced today the acquisition of the ACT portfolio and related assets from Actium Biosystems, LLC. This move extends Endomagnetics' oncology platform from diagnostics into therapeutics while maintaining synergies with its magnetic nanoparticle technology.